Team Announcement

Tower Mains is pleased to welcome Victoria Macleod to the team as Administrative Associate. Victoria has experience working in clinical and event/hospitality settings, and a degree in History of Art and [...]



Tower Mains is pleased to announce two important appointments as part of our strategic growth. Cate Ovington has been appointed as the Head of Quality Management and Shona Ross as [...]


Pharma News Update January 2021

COVID-19 Vaccine Development Moderna COVID-19 Vaccine Has Neutralising Activity Against Emerging Virus Variants On 25th January 2021, Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced results [...]

28-January-2021|Pharma News|

Pharma News Update December 2020

COVID-19 Vaccine Development Russia’s COVID-19 Vaccine Data Shows 91.4% Efficacy Rate On 14th December 2020, Russian coronavirus vaccine developers published fresh results from their trial of the Sputnik V vaccine [...]

18-December-2020|Pharma News|

Regulatory News Update November 2020

Medicines and Healthcare products Regulatory Agency (MHRA) MHRA draft guidance on randomised controlled trials generating real-world evidence to support regulatory decisions A draft guidance on randomized controlled trials generating real-world [...]

30-November-2020|Regulatory News|

Pharma News Update November 2020

COVID-19 Vaccine Development Oxford University and AstraZeneca’s AZD1222 Vaccine Meets Primary Efficacy Endpoint in Preventing COVID-19 On 23rd November 2020, AstraZeneca announced positive high-level results from an interim analysis of [...]

26-November-2020|Pharma News|